Alzheimer Europe's May 2025 newsletter brings you the latest news on developments in the dementia field, across Europe and beyond.

Summaries of a few of our top stories appear below.

Our monthly newsletter reaches almost 11,000 people, who have an interest in dementia, from across Europe and beyond.

We are always happy to receive feedback, or suggestions regarding news items to share.

Alzheimer Europe has signed a statement coordinated by the InRAD (International Registry for Alzheimer’s Disease and Other Dementias) Foundation, welcoming the approval of lecanemab in Europe and recognising the need to address questions surrounding its clinical use, including its safety and effectiveness in the real world.

A new Austrian Dementia Report 2025 provides a detailed analysis of healthcare provision, social support, as well as examining the living conditions of people with dementia and informal caregivers. The report was developed by Gesunheidt Österreich on behalf of the Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection.

On 23 May 2025, during the 78th World Health Assembly in Geneva (Switzerland), a six-year extension to the Global Action Plan on the Public Health Response to Dementia was adopted. This followed a recommendation adopted by the Executive Board of the World Health Organization (WHO) in February of this year.

Alzheimer Europe has newly launched a public opinion poll examining attitudes towards dementia research participation and data sharing. This poll is part of a broader initiative, which aims to understand motivators and barriers to dementia research participation and data sharing. We would appreciate your support!